RE:RE:RE:RE:RE:The last patient update was September 30, 2019 The Clinical Trials are one thing but maintaining (for the layman rather than those with a given level of intelligence) a purposeful dynamic to reflect the Company’s progress outside of the Trials and the prospective value that this should bring to the stock price is an equally important aspect of the good management of a Company such as this.
It could almost be regarded as an achievement that during six years here they’ve managed to prove the science and move it from the Bench to the Clinic without any significant increase in market cap except for short periods prior to fundraisings when glimmers of hope have been engendered.